{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:01:01Z","timestamp":1789509661665,"version":"build-2803163510"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FIRB (Futuro in Ricerca-Bando Giovani) 2010, project number RBFR10A0G1"],"award-info":[{"award-number":["FIRB (Futuro in Ricerca-Bando Giovani) 2010, project number RBFR10A0G1"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation mainly affecting the joints leading to cartilage and bone destruction. The definition of seropositive or seronegative RA is based on the presence or absence of rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPAs). Other autoantibodies have been identified in the last decade such as antibodies directed against carbamylated antigens, peptidyl-arginine deiminase type 4 and v-Raf murine sarcoma viral oncogene homologue B. In order to identify relevant autoantigens, we screened a random peptide library (RPL) with pooled IgGs obtained from 50 patients with seronegative RA. Patients\u2019 sera were then used in an ELISA test to identify the most frequently recognized peptide among those obtained by screening the RPL. Sera from age- and sex-matched healthy subjects were used as controls. We identified a specific peptide (RA-peptide) recognized by RA patients\u2019 sera, but not by healthy subjects or by patients with other immune-mediated diseases. The majority of sera from seronegative and seropositive RA patients (73.8% and 63.6% respectively) contained IgG antibodies directed against the RA-peptide. Interestingly, this peptide shares homology with some self-antigens, such as Protein-tyrosine kinase 2 beta, B cell scaffold protein, Liprin-alfa1 and Cytotoxic T lymphocyte protein 4. Affinity purified anti-RA-peptide antibodies were able to cross react with these autoantigens. In conclusion, we identified a peptide that is recognized by seropositive and, most importantly, by seronegative RA patients\u2019 sera, but not by healthy subjects, conferring to this epitope a high degree of specificity. This peptide shares also homology with other autoantigens which can be recognized by autoantibodies present in seronegative RA sera. These newly identified autoantibodies, although present also in a percentage of seropositive RA patients, may be considered as novel serum biomarkers for seronegative RA, which lacks the presence of RF and\/or ACPAs.<\/jats:p>","DOI":"10.3389\/fimmu.2021.753400","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T19:04:35Z","timestamp":1633547075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach"],"prefix":"10.3389","volume":"12","author":[{"given":"Caterina","family":"Bason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Argentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Beri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnaneshwer","family":"Jadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Tinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"B1","article-title":"Overview of Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid Arthritis","volume":"18","author":"Gibofsky","year":"2012","journal-title":"Am J Manag Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An Overview of Autoantibodies in Rheumatoid Arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584","article-title":"Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e000057","DOI":"10.1136\/rmdopen-2015-000057","article-title":"Rheumatoid Arthritis Treatment: The Earlier the Better to Prevent Joint Damage","volume":"1","author":"Monti","year":"2015","journal-title":"RMD Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2010.10.003","article-title":"Novel Autoantibody Markers for Early and Seronegative Rheumatoid Arthritis","volume":"36","author":"Somers","year":"2011","journal-title":"J Autoimmun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0195550","DOI":"10.1371\/journal.pone.0195550","article-title":"Clinical Management of Seronegative and Seropositive Rheumatoid Arthritis: A Comparative Study","volume":"13","author":"Choi","year":"2018","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.04.018","article-title":"Anti-Citrullinated Protein\/Peptide Antibodies (ACPA) in Rheumatoid Arthritis: Specificity and Relation With Rheumatoid Factor","volume":"4","author":"Vander Cruyssen","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and Predictive Value of Anti-Cyclic Citrullinated Protein Antibodies in Rheumatoid Arthritis: A Systematic Literature Review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1196\/annals.1313.031","article-title":"Association of Anti-Cyclic Citrullinated Peptide Antibodies, Anti-Citrullin Antibodies, and IgM and IgA Rheumatoid Factors With Serological Parameters of Disease Activity in Rheumatoid Arthritis","volume":"1050","author":"Greiner","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.22868","article-title":"The Performance of Anti-Cyclic Citrullinated Peptide Antibodies in Predicting the Severity of Radiologic Damage in Inflammatory Polyarthritis: Results From the Norfolk Arthritis Register","volume":"56","author":"Bukhari","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel237","article-title":"Very Recent Onset Rheumatoid Arthritis: Clinical and Serological Patient Characteristics Associated With Radiographic Progression Over the First Years of Disease","volume":"46","author":"Machold","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.012","article-title":"Anti-Citrullinated Peptides as Autoantigens in Rheumatoid Arthritis-Relevance to Treatment","volume":"13","author":"Sakkas","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM Isotypes Against Cyclic Citrullinated Peptide Precede the Development of Rheumatoid Arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01113","article-title":"Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance","volume":"9","author":"Martinez-Prat","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-018-0042-8","article-title":"Clinical and Pathophysiologic Relevance of Autoantibodies in Rheumatoid Arthritis","volume":"59","author":"de Brito Rocha","year":"2019","journal-title":"Adv Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond Citrullination: Other Post-Translational Protein Modifications in Rheumatoid Arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies Recognizing Carbamylated Proteins Are Present in Sera of Patients With Rheumatoid Arthritis and Predict Joint Damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.37830","article-title":"Anti-Carbamylated Protein Antibodies are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis","volume":"65","author":"Shi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B20","article-title":"Anti-Homocitrullinated Protein Antibody Isotype Usage in Rheumatoid Arthritis and Their Unaffected First-Degree Relatives","volume":"35","author":"Bell","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1136\/annrheumdis-2016-210892","article-title":"Disease-Modifying Treatment in Rheumatoid Arthritis: Treat Early and do Not Forget to Try to Taper and Stop","volume":"76","author":"Ajeganova","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B22","article-title":"Anti-Carbamylated Protein Antibodies in Unaffected First-Degree Relatives of Rheumatoid Arthritis Patients: Lack of Correlation With Anti-Cyclic Citrullinated Protein Antibodies and Rheumatoid Factor","volume":"33","author":"Alessandri","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.02.009","article-title":"Autoantibodies to PAD4 and BRAF in Rheumatoid Arthritis","volume":"11","author":"Auger","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.23596","article-title":"Association of Autoimmunity to Peptidyl Arginine Deiminase Type 4 With Genotype and Disease Severity in Rheumatoid Arthritis","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102470","article-title":"Homocysteinylated Alpha 1 Antitrypsin as an Antigenic Target of Autoantibodies in Seronegative Rheumatoid Arthritis Patients","volume":"113","author":"Colasanti","year":"2020","journal-title":"J Autoimmun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/80533","article-title":"Systemic Sclerosis Immunoglobulin G Autoantibodies Bind the Human Cytomegalovirus Late Protein UL94 and Induce Apoptosis in Human Endothelial Cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e57729","DOI":"10.1371\/journal.pone.0057729","article-title":"In Type 1 Diabetes a Subset of Anti-Coxsackievirus B4 Antibodies Recognize Autoantigens and Induce Apoptosis of Pancreatic Beta Cells","volume":"8","author":"Bason","year":"2013","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11028-2","article-title":"Autoantibodies to Inner Ear and Endothelial Antigens in Cogan\u2019s Syndrome","volume":"360","author":"Lunardi","year":"2002","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098","article-title":"Classification Criteria for Systemic Sclerosis: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.015","article-title":"The Classification and Diagnostic Criteria of Ankylosing Spondylitis","author":"Raychaudhuri","year":"2014","journal-title":"J Autoimmun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32835fd8d5","article-title":"Psoriatic Arthritis and Spondyloarthritis Assessment and Management Update","volume":"25","author":"Mease","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316682099","article-title":"Congenital Heart Block and Immune Mediated Sensorineural Hearing Loss: Possible Cross Reactivity of Immune Response","volume":"26","author":"Bason","year":"2017","journal-title":"Lupus"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0898-6568(99)00076-5","article-title":"RAFTK\/Pyk2-Mediated Cellular Signalling","volume":"12","author":"Avraham","year":"2000","journal-title":"Cell Signal"},{"key":"B34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-12-386041-5.00005-4","article-title":"Focal Adhesion Kinase: Exploring Fak Structure to Gain Insight Into Function","volume":"288","author":"Hall","year":"2011","journal-title":"Int Rev Cell Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10050139","article-title":"Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer","volume":"10","author":"Zhu","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200207036","article-title":"Regulation of the Formation of Osteoclastic Actin Rings by Proline-Rich Tyrosine Kinase 2 Interacting With Gelsolin","volume":"160","author":"Wang","year":"2003","journal-title":"J Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0464-6","article-title":"Focal Adhesion Kinase Is Required for Synovial Fibroblast Invasion, But Not Murine Inflammatory Arthritis","volume":"16","author":"Shelef","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-10-141","article-title":"Functional Activation of Proline-Rich Tyrosine Kinase2 (PYK2) in Peripheral Blood Mononuclear Cells From Patients With Systemic Lupus Erythematosus","volume":"10","author":"Wang","year":"2009","journal-title":"BMC Musculoskelet Disord"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.01.002","article-title":"BANK Negatively Regulates Akt Activation and Subsequent B Cell Responses","volume":"24","author":"Aiba","year":"2006","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e59842","DOI":"10.1371\/journal.pone.0059842","article-title":"BANK1 and BLK Act Through Phospholipase C Gamma 2 in B-Cell Signaling","volume":"8","author":"Bernal-Quiros","year":"2013","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexcr.2010.09.014","article-title":"Function of Liprins in Cell Motility","volume":"317","author":"de Curtis","year":"2011","journal-title":"Exp Cell Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.054155","article-title":"Liprin-Alpha1 Promotes Cell Spreading on the Extracellular Matrix by Affecting the Distribution of Activated Integrins","volume":"122","author":"Asperti","year":"2009","journal-title":"J Cell Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.01.017","article-title":"Liprin-Alpha1 Affects the Distribution of Low-Affinity Beta1 Integrins and Stabilizes Their Permanence at the Cell Surface","volume":"316","author":"Asperti","year":"2010","journal-title":"Exp Cell Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-8-37","article-title":"Diagnostic Value of Anti-Cyclic Citrullinated Peptide Antibodies in Greek Patients With Rheumatoid Arthritis","volume":"8","author":"Alexiou","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/728610","article-title":"The Role of Citrullinated Protein Antibodies in Predicting Erosive Disease in Rheumatoid Arthritis: A Systematic Literature Review and Meta-Analysis","volume":"2015","author":"Jilani","year":"2015","journal-title":"Int J Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205698","article-title":"Changes in the Anticitrullinated Peptide Antibody Response in Relation to Therapeutic Outcome in Early Rheumatoid Arthritis: Results From the SWEFOT Trial","volume":"75","author":"Kastbom","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2013.822074","article-title":"Identification of Autoantibodies Against Inner Ear Antigens in a Cohort of Children With Idiopathic Sensorineural Hearing Loss","volume":"46","author":"Berti","year":"2013","journal-title":"Autoimmunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/art.24141","article-title":"Modulation of Molecular Imprints in the Antigen-Experienced B Cell Repertoire by Rituximab","volume":"58","author":"Palanichamy","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-009-8096-7","article-title":"Insights Into the Heterogeneity of Human B Cells: Diverse Functions, Roles in Autoimmunity, and Use as Therapeutic Targets","volume":"45","author":"Anolik","year":"2009","journal-title":"Immunol Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00034","article-title":"B-Cell Subsets in the Joint Compartments of Seropositive and Seronegative Rheumatoid Arthritis (RA) and No-RA Arthritides Express Memory Markers and ZAP70 and Characterize the Aggregate Pattern Irrespectively of the Autoantibody Status","volume":"17","author":"Michelutti","year":"2011","journal-title":"Mol Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.04.006","article-title":"The Development of Targeted Therapies in Rheumatoid Arthritis","volume":"31","author":"Vital","year":"2008","journal-title":"J Autoimmun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar2080","article-title":"Fibroblast Activation Protein Is Expressed by Rheumatoid Myofibroblast-Like Synoviocytes","volume":"8","author":"Bauer","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew347","article-title":"Stable Activation of Fibroblasts in Rheumatic Arthritis-Causes and Consequences","volume":"55","author":"Korb-Pap","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2050","article-title":"Synovial Fibroblasts Spread Rheumatoid Arthritis to Unaffected Joints","volume":"15","author":"Lefevre","year":"2009","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/ar4074","article-title":"Epigenetic Contributions in the Development of Rheumatoid Arthritis","volume":"14","author":"Klein","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1385\/IR:31:3:267","article-title":"Focal Adhesion Kinase-Related Protein Tyrosine Kinase Pyk2 in T-Cell Activation and Function","volume":"31","author":"Ostergaard","year":"2005","journal-title":"Immunol Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.114.15.2775","article-title":"Podosomes in Osteoclast-Like Cells: Structural Analysis and Cooperative Roles of Paxillin, Proline-Rich Tyrosine Kinase 2 (Pyk2) and Integrin Alphavbeta3","volume":"114","author":"Pfaff","year":"2001","journal-title":"J Cell Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0199979","DOI":"10.1371\/journal.pone.0199979","article-title":"Bank1 and NF-KappaB as Key Regulators in Anti-Nucleolar Antibody Development","volume":"13","author":"Alkaissi","year":"2018","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes247","article-title":"Altered BANK1 Expression Is Not Associated With Humoral Autoimmunity in Chronic Joint Inflammation","volume":"52","author":"Cantaert","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-017-1503-x","article-title":"BANK1 Alters B Cell Responses and Influences the Interactions Between B Cells and Induced T Regulatory Cells in Mice With Collagen-Induced Arthritis","volume":"20","author":"Yang","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.047266","article-title":"KazrinE Is a Desmosome-Associated Liprin That Colocalises With Acetylated Microtubules","volume":"122","author":"Nachat","year":"2009","journal-title":"J Cell Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.07.021","article-title":"Liprin-Mediated Large Signaling Complex Organization Revealed by the Liprin-Alpha\/CASK and Liprin-Alpha\/Liprin-Beta Complex Structures","volume":"43","author":"Wei","year":"2011","journal-title":"Mol Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2005.08.005","article-title":"Podosomes as Smart Regulators of Cellular Adhesion","volume":"85","author":"Spinardi","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb3036","article-title":"Endothelial Podosome Rosettes Regulate Vascular Branching in Tumour Angiogenesis","volume":"16","author":"Seano","year":"2014","journal-title":"Nat Cell Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/srep24486","article-title":"Liprin-Alpha1 Is a Regulator of Vimentin Intermediate Filament Network in the Cancer Cell Adhesion Machinery","volume":"6","author":"Pehkonen","year":"2016","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.753400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T19:04:39Z","timestamp":1633547079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.753400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":65,"alternative-id":["10.3389\/fimmu.2021.753400"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.753400","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"article-number":"753400"}}